During the past decade, NorthShore University HealthSystem Dermatology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NorthShore University HealthSystem Dermatology" are "Alopecia Areata" (2 trials), "Acne Inversa" (1 trials), "Dermatitis, Atopic" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "NorthShore University HealthSystem Dermatology" in a lesser frequency.

Most popular intervention types in "NorthShore University HealthSystem Dermatology" are "Drug" (5 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "PF-06651600" (2 trials), "ABP 501" (1 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "NorthShore University HealthSystem Dermatology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "NorthShore University HealthSystem Dermatology". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in NorthShore University HealthSystem Dermatology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NorthShore University HealthSystem Dermatology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".